The global mycosis fungoides therapeutics market is anticipated to grow at a significant CAGR during the forecast period (2021-2027). Mycosis fungoides is the most common type of blood cancer known as cutaneous T-cell lymphoma. Cutaneous T-cell lymphoma occurs when certain T-cells become cancerous. These cancers affect the skin and cause different types of lesions on the skin. Mycosis fungoides usually affects adults over age 50.
An increase in prevalence and incidence of mycosis fungoides and new drug approvals accelerate the global mycosis fungoides therapeutics market during the forecast period. In addition, special drug designation for mycosis fungoides drugs is another major factor for the demand of the global mycosis fungoides therapeutics market during the forecast period.
The global mycosis fungoides therapeutics market analysis includes some of the key market players such as Azurity Pharmaceuticals, Inc., Takeda Pharmaceutical Company Limited, Merck & Co., Inc., and Kyowa Kirin Co., Ltd., among others. To maintain a strong position in the market, these market players are adopting various strategic moves, such as product launches, partnerships, collaborations, and mergers and acquisitions. For instance, in June 2021, Innate Pharma SA announced preliminary data from the mycosis fungoides (MF) cohort of Phase 2 TELLOMAK clinical trial, evaluating lacutamab, an anti-KIR3DL2 cytotoxicity-inducing antibody, in an oral presentation at the 16th International Conference on Malignant Lymphoma (16-ICML).
Market Coverage
Competitive Landscape: Azurity Pharmaceuticals, Inc., Takeda Pharmaceutical Company Limited, Merck & Co., Inc., and Kyowa Kirin Co., Ltd., among others.
Key questions addressed by the report
o Recovery Timeline
o Deviation from pre-COVID forecast
o Most affected region and segment
Global Mycosis Fungoides Therapeutics Market by Segment
By Type
• Small Molecules
• Biologics
By Distribution Channel
• Hospital Pharmacies
• Retail Pharmacies
• Others
Global Mycosis Fungoides Therapeutics Market by Regional Analysis
North America
Europe
Asia-Pacific
Rest of the World